| |
| Magyar Hypertonia Társaság |
|
| IX. Gyulai Hypertonia Nap |
 Rendezvény kezdete: 2009.10.02. | Rendezvény vége: 2009.10.02. |
| Helyszín: Gyula, BMKT Pándy Kálmán Kórház, Árvay Terem |
A Békés Megyei Képviselő-testület Pándy Kálmán Kórházának Hypertonia Decentruma, a Magyar Hypertonia Társaság szakmai támogatásával, tisztelettel meghívja Önt a IX. Gyulai Hypertonia Nap keretében megrendezésre kerülő
Újabb lépéssel a terápiás siker felé
című szimpóziumra.
A rendezvény 2009. október 2-án 10:45-kor a BMKT Pándy Kálmán Kórház Árvay termében kerül megrendezésre.
A tudományos programot az SZTE ÁOK 2009. II/00136 kódszámon akkreditálta, a részvételért – tesztírással együtt – 10 kredit pont adható.
A szponzoroknak köszönhetően a rendezvényen való részvétel ingyenes.
Dr. Dudás Mihály
osztályvezető főorvos
a PKK Hypertonia Decentrum vezetője
A program elérhető a kapcsolódó dokumentumban. |
|
|
 |
| |
| Magyar Dermatológiai Társulat |
|
| DHM Digital 2022 - 9th Drug Hypersensitivity Meeting (online, 2022.04.21.) |
| Rendezvény kezdete: 2022.04.21. | Rendezvény vége: 2022.04.21. |
| Helyszín: online |
| A rendezvény Web oldala: https://www.eaaci.org/focused-meetings/dhm-digital-2022 |
9th Drug Hypersensitivity Meeting (DHM) will take place virtually in the EAACI Digital Congress Platform, on April 21, 2022.
This year, DHM will become the perfect platform for our community to have access to the latest and cutting-edge molecular, cellular, and social media tools for allergy diagnosis in alternating theoretical and practical sessions. Participants will learn from experts how to apply these tools and will be presented with the possibility to exchange with peers coming from all over the world.
The scientific programme will include the symposia on virus infection and drug allergy, the mechanism of how viral infection modulates drug allergy, diagnosis of ADR to SARS-CoV-2 vaccines, and more. Some of the scientific highlights of the meeting are:
Biomarkers in DIHS/DRESS
How can viruses induce disruption of drug tolerance
Skin testing with vaccines and components
DHR in HIV patients
New insights into the role of mast cells MRGPRX2
DHM Digital 2022 deadlines to keep in mind:
Early bird registration fee: March 15
Program
Registration |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| DHM Digital 2022 - 9th Drug Hypersensitivity Meeting (online, 2022.04.21.) |
| Rendezvény kezdete: 2022.04.21. | Rendezvény vége: 2022.04.21. |
9th Drug Hypersensitivity Meeting (DHM) will take place virtually in the EAACI Digital Congress Platform, on April 21, 2022.
This year, DHM will become the perfect platform for our community to have access to the latest and cutting-edge molecular, cellular, and social media tools for allergy diagnosis in alternating theoretical and practical sessions. Participants will learn from experts how to apply these tools and will be presented with the possibility to exchange with peers coming from all over the world.
The scientific programme will include the symposia on virus infection and drug allergy, the mechanism of how viral infection modulates drug allergy, diagnosis of ADR to SARS-CoV-2 vaccines, and more. Some of the scientific highlights of the meeting are:
Biomarkers in DIHS/DRESS
How can viruses induce disruption of drug tolerance
Skin testing with vaccines and components
DHR in HIV patients
New insights into the role of mast cells MRGPRX2
DHM Digital 2022 deadlines to keep in mind:
Early bird registration fee: March 15
Program
Registration |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| IPC Congress Symposia (Boston, MA, USA, 2022.03.24.) |
| Rendezvény kezdete: 2022.03.24. | Rendezvény vége: 2022.03.24. |
| Helyszín: USA, Boston, |
| A rendezvény Web oldala: https://www.psoriasiscouncil.org/aad_2022_agenda.htm |
Hot topics in psoriasis: A focus on treatment innovationsAmerican Academy of Dermatology Annual Meeting (AAD) | Boston, MA
Thursday, March 24 | 1:00 – 3:00 pm EDT
Program chair: Craig Leonardi, United States
Program faculty: Andy Blauvelt, United States, and Charles Lynde, Canada
This symposium is supported in part by Abbvie, Eli Lilly and Company, and UCB.
Agenda
WELCOME AND INTRODUCTION Craig Leonardi How to select a systemic treatment for your patient given a palette of at least 13 optionsCraig Leonardi
Innovations in topical treatments for psoriasis
Charles Lynde
Innovations in systemic treatments for psoriasis
Andy Blauvelt
Q & A – Speaker panel
Craig Leonardi
CLOSING AND ADJOURN
Craig Leonardi REGISTER NOW |
|
|
|
|
|
